Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021243
Company: PHARMACIA UPJOHN
Company: PHARMACIA UPJOHN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
AZULFIDINE EN-TABS | SULFASALAZINE | 500MG | TABLET; ORAL | Prescription | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/18/2000 | ORIG-1 | Approval | Type 6 - New Indication (no longer used) | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/007073s133,020465s000,021243s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/007073Orig1s133,020465Orig1s000,021243Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21243_Azulfidine.cfm |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
08/18/2000 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/007073s133,020465s000,021243s000lbl.pdf |